AMMONIUM SUCCINATE IN THE TREATMENT OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA

Shaykenov Oleg Vyacheslavovich, Postgraduate student, Ulyanovsk state university, morkvahi@mail.ru
Peskov Andrey Borisovich, Doctor of medicine, professor, dean of the department of postgraduate, additional and higher nursing education, Ulyanovsk state university, abp_sim@mail.ru
Maevsky Evgeny Ilyich, Doctor of medicine, professor, deputy director of the Institute of theoretical and experimental biophysics of the Russian Academy of sciences (Moscow region, Pushchino) , eim1@rambler.ru
Peskova Svetlana Vladimirovna, Lecturer, Medical college, Ulyanovsk state university, abp_sim@mail.ru
Esefyeva Natalya Borisovna, Postgraduate student, Ulyanovsk state university, pdo@ulsu.ru

616.24-002-08:615.739

During placebo controlled trial 120 patients with diagnosis «Acute extrahospital pneumonia» (AEP) were under observation during 1 month. Ammonia succinatis (AS) or placebo (300 mg every day, 7-days course) were added to the traditional AEP treatment (antibacterial and detoxication therapy) at the 1st, 10th or 20th day of treatment initiation. It has been shown that the main effects of SA makes possible to reduce displays of asthenia and intoxication.

ammonia succinatis, acute extrahospital pneumonia.